Sanofi | SNY - Loan Capital


Sanofi reported EUR15.72B in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
AbbVie USD 58.94B 4.03B Dec/2025
Amgen USD 51.89B 1.88B Mar/2026
AstraZeneca USD 25.96B 177M Mar/2026
Bristol-Myers Squibb USD 42.15B 698M Mar/2026
Canopy Growth CAD 224.99M 1.34M Dec/2025
Drreddys Laboratories INR 129.19M 1.84M Dec/2025
Eli Lilly USD 39.37B 1.5B Mar/2026
Galapagos EUR 5.19M 574K Dec/2025
Genmab DKK 5.14B 5.01B Dec/2025
GlaxoSmithKline GBP 14.01B 696M Mar/2026
Glaxosmithkline GBP 19.82B 203.13M Dec/2025
J&J USD 37.53B 1.91B Mar/2026
Merck USD 46.67B 77M Mar/2026
Novartis USD 37.45B 7.86B Mar/2026
Novartis USD 29.59B 5.35B Dec/2025
Pacira USD 367.66M 4.53M Mar/2026
Perrigo USD 3.6B 4.5M Dec/2025
Pfizer USD 60.57B 1.08B Mar/2026
Phibro Animal Health USD 603.6M 5.92M Dec/2025
Prestige Brands USD 1.05B 39.73M Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 13.84B 1.88B Mar/2026
Sanofi EUR 15.72B 150.06M Dec/2025
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
UCB EUR 2.18B 634M Dec/2025
Zoetis USD 9.04B 1.97B Dec/2025